The opioid crisis has taught us the lesson that well-intentioned medicine, when paired with misaligned incentives, can produce devastating public health outcomes. What was introduced in the 1990s as revolutionary pain prescriptions, turned out to become a health epidemic catalyzed by large pharmaceutical companies selling a product in which there was direct knowledge that long-term usage led to difficulties in patients withdrawing. Prescribing physicians contributed to the epidemic not out of greed or malintent, but sympathy. A place of…